Biora Therapeutics, Inc.
BIORQ
$0.00
$0.000.00%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 74.95% | 136.31% | 75.98% | -- | -1,336.33% |
| Total Depreciation and Amortization | -11.20% | -33.73% | -28.57% | -- | -38.12% |
| Total Amortization of Deferred Charges | 153.93% | -11.23% | 418.45% | -- | 3.07% |
| Total Other Non-Cash Items | -97.48% | -1,077.66% | -873.42% | -- | 718.03% |
| Change in Net Operating Assets | 158.18% | -1.85% | -29.60% | -- | -36.09% |
| Cash from Operations | 20.88% | 5.76% | -3.29% | -- | -12.53% |
| Capital Expenditure | -1,800.00% | -800.00% | 6.25% | -- | 99.39% |
| Sale of Property, Plant, and Equipment | -- | -100.00% | 100.00% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -1,800.00% | -847.37% | 50,183.33% | -- | 99.39% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 100.55% | -- | -78.27% | -- | -89.09% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 42.46% | -69.40% | 36.03% | -- | 3.41% |
| Cash from Financing | 332.44% | -26.12% | -57.78% | -- | -92.82% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 84.66% | -37.00% | -18,991.30% | -- | -21.29% |